期刊文献+

高白细胞急性髓系白血病TGF-β_1的表达及其临床意义 被引量:1

Expression of TGF-β_1 in hyperleukocytic acute myeloid leukemia and its clinical significance
下载PDF
导出
摘要 目的本文旨在探讨转化生长因子β-1(transform growth factorβ1,TGF-β1)在高白细胞急性髓系白血病(acute myeloid leukemia,AML)发病中的作用。方法分别采用实时定量PCR、流式细胞术及酶联免疫反应检测38例AML患者骨髓单个核细胞(bone marrow mononuclear cells,BMMNC)内TGF-β1mRNA浓度、48例AML患者BMMNC的TGF-β1蛋白和40例AML患者血清TGF-β1蛋白质量浓度。结果高白细胞AML患者、非高白细胞AML患者和正常对照者的TGF-β1mRNA浓度差异无统计学意义,高白细胞和非高白细胞AML患者的胞内TGF-β1蛋白质量浓度显著高于正常对照者,血清TGF-β1蛋白质量浓度显著低于正常对照者。高白细胞和非高白细胞AML患者之间的胞内和血清TGF-β1蛋白质量浓度差异无统计学意义。高白细胞与非高白细胞AML患者之间胞内及血清TGF-β1质量浓度与FAB亚型无关。结论 AML患者血清TGF-β1浓度降低可能参与了疾病的发生,而血清TGF-β1的减少可能并不能反映BMMNC合成TGF-β1减少。TGF-β1对高白细胞AML的发病并未产生重要影响。 Objective To investigate the role of transform growth factor β1( TGF-β1) in pathogenesis of hyperleukocytic acute myeloid leukemia( AML). Methods The mRNA transcription levels of TGF-β1from bone marrow mononuclear cells( BMMNC) in 38 AML patients,protein expression levels of intracellular TGF-β1from BMMNC in 48 AML patients,and serum levels of TGF-β1from 40 AML patients were measured by real-time fluorescence quantitative polymerase chain reaction( RQ-PCR),flow cytometry,and doubleantibody sandwich enzyme-linked immunosorbent assay( ELISA),respectively. Results The relative levels of the TGF-β1gene expression among hyperleukocytic AML patients,non-hyperleukocytic AML patients,and NC has no significant difference( P 0. 05).The protein expression levels of TGF-β1in both hyperleukocytic AML and non-hyperleukocytic AML patients were significantly higher than that in NC( P 0. 05),the plasma levels were significantly lower than that in NC( P 0. 05). There was no significant difference in intracellular protein expression levels and plasma levels of TGF-β1between hyperleukocytic AML and non-hyperleukocytic AML patients( P 0.05). There was no significant difference in intracellular protein expression levels and plasma levels of TGF-β1between the FAB subtypes in hyperleukocytic and non-hyperleukocytic AML( P 0. 05). Conclusion Decreased serum levels of TGF-β1may be involved in the pathogenesis of AML. However,decreased TGF-β1serum levels may not reflect reduced TGF-β1production by BMMNC. Our study showed that TGF-β1had no important impact on the pathogenesis of hyperleukocytic AML.
出处 《首都医科大学学报》 CAS 2014年第5期555-559,共5页 Journal of Capital Medical University
基金 首都医学发展科研基金项目(2009-3192) 北京市优秀人才培养资助个人项目(20071D0900700341)~~
关键词 转化生长因子Β-1 急性髓系白血病 高白细胞 transform growth factor β1 acute myeloid leukemia hyperleukocytic
  • 相关文献

参考文献15

  • 1Ganzel C,Becker J,Mintz P D,et al.Hyperleukocytosis,leukostasis and leukapheresis:practice anagement[J] .Blood Rev,2012,26(3):117-122.
  • 2Jain R,Bansal D,Marwaha R K.Hyperleukocytosis:emergency management[J] .Indian J Pediatr,2013,80(2):144-148.
  • 3Ikushima H,Miyazono K.TGF-beta signalling:a complex web in cancer progression[J] .Nat Rev Cancer,2010,10(6):415-424.
  • 4Wu Y,Chen P,Huang H F,et al.Reduction of transforming growth factor-β1 expression in leukemia and its possible role in leukemia development[J] .Leuk Lymphoma,2012,53(1):145-151.
  • 5Szczepanski M J,Szajnik M,Czystowska M,et al.Increased frequency and suppression by regulatory T cells in patients with acute myelogenous leukemia[J] .Clin Cancer Res,2009,15(10):3325-3332.
  • 6Lin H K,Bergmann S,Pandolfi P P.Deregulated TGF-beta signaling in leukemogenesis[J] .Oncogene,2005,24(37):5693-5700.
  • 7陈元仲,吕联煌,汪玲,彭永麟,JPCaen,韩忠朝.白血病细胞TGFβ_1及其受体基因表达与白血病患者血清TGFβ_1测定及其意义[J].中华血液学杂志,1998,19(11):576-580. 被引量:15
  • 8凡治国,张连生,柴晔,曾鹏云,吴重阳.Th17细胞水平的变化与急性髓系白血病发病关系的探讨[J].中华血液学杂志,2010,31(9):617-620. 被引量:22
  • 9Szczepanski M J,Szajnik M,Welsh A,et al.Blast-derived microvesicles in sera from patients with acute myeloid leukemia suppress natural killer cell function via membrane-associated transforming growth factor-beta1[J] .Haematologica,2011,96(9):1302-1309.
  • 10周慧,王建虹,闵捷.老年急性髓系白血病治疗的研究进展[J].中华肿瘤防治杂志,2011,18(10):816-820. 被引量:8

二级参考文献68

  • 1Veldhoen M,Hocking RJ,Atkins CJ,et al.TGF-β in the context of an inflammatory cytokine milieu supports denovo differentiation of IL-17-producing T cells.Immunity,2006,24:179-189.
  • 2Bettlli E,Carrier Y,Gao W,et al.Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells.Nature,2006,441:235-238.
  • 3Beyer M,Schultze JL.Regulatory T cells in cancer.Blood,2006,108:804-811.
  • 4Wang X,Zheng J,Liu J,et al.Increased population of CD4^+ CD25^+ regulatory T cells with their higher apoptotic and proliferating status in peripheral blood of acute myeloid leukemia patients.Eur J Haematol,2005,75:468-476.
  • 5Harrington LE,Hatton RD,Mangan PR,et al.lnterleukin 17-producing CD4^+ efector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages.Nat Immunol,2005,6:1123-1132.
  • 6Bettelli E,Korn T,Kuchroo VK.Th17:the third member of the effector T cell trilogy.Curr Opin Immuno1,2007,19:1-6.
  • 7Manel N,Unutmaz D,Littman DR.The differentiation of human Th17 cells requires trans forming growth factor-beta and induction of the nuclear receptor RORgammat.Nat Immunol,2008,9:641-649.
  • 8Numasaki M,Watanabe M,Suzuki T,et al.IL-17 enhances the net aagiogenic activity and in vivo growth of human non-small cell lung cancer in SCD mice through promoting CXCR-2-dependent angiogenesis.lmmunol,2005,175:6177-6189.
  • 9Zhang B,Rong G,Wei H,et al.The prevalence of Th17 cells in patients with gastric cancer.Bioehem Biophys Res Commun,2008,374:533-537.
  • 10Gogas H,Ioannovich J,Dafni U,et al.Prognostic significance of autoimmunity during treatment of melanoma with interferon.N Engl J Med,2006,354:709-718.

共引文献49

同被引文献7

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部